DIGNITANA LAUNCHES DIGNICAP® MOBILE APP FOR U.S. ...
About DignitanaDignitana develops a patented scalp cooling system, DigniCap®, that reduces chemotherapy-induced hair loss. Dignitana's patented DigniCap® system has demonstrated excellent scientific results in clinical studies. More than eight out of ten treated patients were able to retain enough of their hair to eliminate the need for a wig.
About DigniCap®DigniCap® provides a reliable method of continuous scalp cooling with high efficacy and an acceptable level of patient comfort. The system consists of a form-fitting silicone cap connected to a cooling and control unit. An elastic, insulating outer cap made of neoprene is used to ensure the best fit and treatment temperature. Please visit our new website for more product information www.dignicap.com.
Investor relationsDignitana is a Swedish medical technology company listed on the NASDAQ OMX First North stock exchange. The company is currently focusing on a widespread market launch of the DigniCap® system – a product that counteracts chemotherapy-related hair loss in cancer patients and significantly contributes to improving patient well being and quality of life.
DIGNITANA CELEBRATES FIRST ANNIVERSARY OF FDA CLEARANCE FOR DIGNICAP® SYSTEM AT SAN ANTONIO BREAST CANCER SYMPOSIUM
One year to the date of receiving FDA Clearance fo...
Dignitana has entered an exclusive partnership wit...
Address:Our address is:
SE-226 60 Lund.